Safety and efficacy of intranasal ketamine for acute postoperative pain

Acute Pain

Volumn 9, Issue 4, 2007, Pages 183-192

  Christensen, Kyle ^a   Rogers, Elizabeth ^b   Green, Geoff A ^b   Hamilton, Douglas A ^b   Mermelstein, Fred ^b   Liao, Edward ^b   Wright, Curtis ^b   Carr, Daniel B ^b  

^a Wasatch Oral Surgery   (United States)

^b Javelin Pharmaceuticals Inc   (United States)

Author keywords

Analgesia; Dental pain; Intranasal administration; Ketamine; Postoperative pain

Indexed keywords

KETAMINE; PLACEBO;

ADOLESCENT; ANALGESIA; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HALLUCINATION; HEARING DISORDER; HUMAN; HYPERTENSION; MALE; MENTAL CONCENTRATION; NAUSEA; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NOSE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PULSE OXIMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SYNESTHESIA; TACHYCARDIA; TOOTH EXTRACTION; TREATMENT OUTCOME; VISUAL DISORDER; VISUAL HALLUCINATION; VITAL SIGN; VOMITING;

EID: 36348986545     PISSN: 13660071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acpain.2007.09.001     Document Type: Article

References (22)

1. Marshall B.E., and Longnecker D.E. General anesthetics. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., and Goodman Gilman A. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 9th Ed. vol. 1752 (1996), McGraw-Hill, New York 307-330
2. White P.F., Way W.L., and Trevor A.J. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 56 (1982) 119-136
3. Tucker A.P., Kim Y.I., Nadeson R., and Goodchild C.S. Investigation of the potentiation of the analgesics effects of fentanyl by ketamine in humans: a double-blinded, randomized, placebo controlled crossover study of experimental pain. Anesthesiology 5 (2005) 2
4. Carr D.B., Goudas L.C., Denman W.T., Brookoff D., Staats P.S., Brennen L., et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain 108 (2004) 17-27
5. Diaz J.H. Intranasal ketamine preinduction of paediatric outpatients. Paediatr Anaesth 7 4 (1997) 273-278
6. Kulbe J. The use of ketamine nasal spray for short-term analgesia. Home Health Nurse 16 6 (1998) 367-370
7. Malinovsky J.M., Servin F., Cozian A., Lepage J.U., and Pinaud M. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth 77 2 (1996) 203-207
8. Visser E., and Schug S.A. The role of ketamine in pain management. Biomed Pharmacol 60 (2006) 341-348
9. Silbert B.S., Osgood P.F., and Carr D.B. Burn pain. In: Yaksh T.L., Lynch III C., Zapol W.M., Maze M., Biebuyck J.F., and Saidman L.J. (Eds). Anesthesia: Biologic Foundations (1998), Lippincott-Raven Publishers, Philadelphia 759-773
10. Sheckler M.T., Mermelstein F., Hamilton D.A., and Carr D. Nasal delivery of analgesics. ONDrug Deliv (2005) 17-19
11. Chien Y.W., Su K.S.E., and Chang S.F. Chapter 1: Anatomy and physiology of the nose. In: Swarbrick J. (Ed). Nasal systemic drug delivery (1989), Marcel Dekker, New York 1-26
12. Cooper S.A., and Beaver W.T. A model to evaluate mild analgesics in oral surgery outpatients. Clin Pharmacol Ther 20 (1976) 241-250
13. Forbes J.A. Oral surgery. In: Max M.B., Portenoy R.K., and Laska E.M. (Eds). The design of analgesic trials. Advances in pain research and therapy 18 (1991), Raven, New York 347-374
14. Eide P.K., Jørum E., Stubhaug A., Bremnes J., and Breivik H. Relief of post-herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 58 (1994) 347-354
15. Weg S, 1998, personal communication.
16. Wermeling D.P., Miller J.L., and Rudy A.C. Systemic intranasal drug delivery: concepts and applications. Drug Deliv Technol 2 (2002) 56-61
17. Cepeda M.S., Africano J.M., Polo R., Alcala R., and Carr D.B. What decline in pain intensity is meaningful to patients with acute pain?. Pain 105 (2003) 151-157
18. Beecher H.J. The powerful placebo. JAMA 159 (1955) 1602-1606
19. Mistry R.B., and Nahata M.C. Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy 25 (2005) 1104-1111
20. Bowdle T.A., Radant A.D., Cowley D.S., Kharasch E.D., Strassman R.J., and Roy-Byrne P.P. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 88 (1998) 82-88
21. Schley M., Topfner S., Wiech K., Schaller H.E., Konrad C.J., Schmelz M., et al. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees. Eur J Pain 11 (2007) 299-308
22. Visser E.J. Chronic post-surgical pain: epidemiology and clinical implications for acute pain management. Acute Pain 8 (2006) 73-81